cid:image001.jpg@01D158FE.B69B8D00
V I S I T I N G S P E A K E R & S E M I N A R S E R I E S
NEUROSCIENCE TRAINEE LUNCH
Thursday, April 6th, 2017
12:00 Noon | SR415 Kleysen Institute for Advanced Medicine
V I S I T I N G S P E A K E R
JEFFREY KLEIM, PH.D https://sbhse.engineering.asu.edu/faculty-and-staff/faculty/jeff-kleim/ ASSOCIATE DIRECTOR
SCHOOL OF BIOLOGICAL AND HEALTH SYSTEMS ENGINEERING
ARIZONA STATE UNIVERSITY
Abstract: The capacity for the nervous system to structurally and functionally adapt (neural plasticity) has been described for more than a century. Decades of neuroanatomical, neurophysiological and molecular studies have revealed that neural plasticity is an evolutionarily conserved, fundamental property of all
nervous tissue. It is critical for maintaining normal brain function and yet can also manifest into various forms of brain dysfunction. While we still do not fully understand the complexity of the human nervous system, its response to disease/injury and capacity for recovery, treatments designed to harness endogenous neural plasticity to overcome neurological impairment continue to emerge. Specifically, the characterization of key behavioral and neurobiological signals that drive neural plasticity, in combination with advances in biomedical engineering, regenerative medicine and genomics, have created opportunities to develop novel therapeutic interventions. Evidence from both animal and clinical studies will be presented that demonstrate how modulating specific elements of motor rehabilitation can enhance functional outcome and cortical reorganization after stroke. Further, the viability of many adjuvant therapies for augmenting neural plasticity to enhance the impact of motor rehabilitation will be presented.
Kelly Jorundson Coordinator, Membership & Operations Manitoba Neuroscience Network
Email: mailto:kjorund@sbrc.ca kjorund@sbrc.ca Tel: 204.235.3939 Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies. ******************************************
http://www.manitobaneuroscience.ca/ cid:image003.jpg@01D159B3.9F0B9710
https://www.facebook.com/manitobaneuroscience/?fref=ts cid:image007.png@01D29326.7E26D480 https://www.instagram.com/manitobaneuroscience/ cid:image009.jpg@01D29326.7E26D480 https://twitter.com/manitobaneuro cid:image010.png@01D29326.7E26D480
